[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"thyroid-disorders\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:thyroid-disorders":36},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":20,"conditions":21,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":4},"100597547",false,"NCT07059910","Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment","Inclusion Criteria:\n\n* ITP patients will be classified as newly diagnosed, persistent and chronic based on duration less than 3 months, 3-12 months, and more than 12 months respectively.\n\n  * refractory ITP patients.\n\nExclusion Criteria:\n\n* patients with history of thyroidectomy\n\n  * patients with history of drug induced ITP\n  * patients with history of HCV, HBV and HIV infection.\n  * Patients who refuse to contribute in this study.","ALL","18 Years",{"count":17,"type":18},100,"ESTIMATED","OBSERVATIONAL","Prevalence of thyroid disorders in patients with immune thrombocytopenic purpura and its impact on treatment",[22,23],"Immune Thrombocytopenic Purpura","Thyroid Disorders","NOT_YET_RECRUITING","2025-07-13",{"date":27,"type":28},"2025-07-17","ACTUAL",{"date":30,"type":18},"2025-07",{"date":32,"type":18},"2026-08-15",{"name":34,"class":35},"Assiut University","OTHER",""]